Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-151769
Filing Date
2021-12-20
Accepted
2021-12-20 17:03:41
Documents
1
Period of Report
2021-12-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2135958-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2135958-1_4seq1.xml 4 3725
  Complete submission text file 0001104659-21-151769.txt   5152
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
Osmotica Pharmaceuticals plc (Issuer) CIK: 0001739426 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 CROSSING BOULEVARD C/O OSMOTICA PHARMACEUTICALS PLC BRIDGEWATER NJ 08807
Business Address
Schaub James (Reporting) CIK: 0001752153 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38709 | Film No.: 211505959